- - Composition for treating Epstein-Barr virus infection comprising a Epstein-Barr virus micro RNA inhibitor

摘要

The present invention relates to a pharmaceutical composition comprising an inhibitor against Epstein-Barr virus microRNA as an active ingredient A composition for treating Epstein-Barr virus infection, and a method for screening Epstein-Barr virus infection therapeutic using Epstein-Barr virus microRNA. Using the composition of the present invention, EBV-infected cells can be destroyed by the host''s immune system by inducing the chronic life cycle of EBV. Therefore, it can be usefully used for the prevention or treatment of diseases caused by EBV infection including various cancers. Also, by using the method of the present invention, it is possible to screen the Epstein-Barr virus infection therapeutic agent having an excellent antiviral effect by inducing the life cycle of Epstein-Barr virus.